Bioinformatics and Computational Biology Conference
Dr. Eng. Giulio Spinozzi, ERC-funded postdoc, presented his abstract titled “A Comprehensive RNA-Seq pipeline includes m...
26 November, 2019
This project has received funding from the European Research Council (ERC) under the European Union’s
Keywords
Acute myeloid leukemia (AML)
Leukemogenesis
Gene mutations
Synthetic lethality
Drug development
Target therapy
Summary of the project
In the wide genomic landscape of acute myeloid leukemia (AML), a major breakthrough was the discovery in 2005, by the research group lead by Prof. Brunangelo Falini at Perugia University, of the NPM1 gene mutations as the most frequent genetic lesion in AML, accounting for about one-third of all adult AML.
P.I. Profile
The Principal Investigator (PI), Maria Paola Martelli is a MD, PhD, Associate Professor and Assistant Clinical Director at the Hematology section (Head: Prof. Brunangelo Falini), Department of Medicine, University of Perugia.
Latest news
-
-
The first SOHO Italian Conference
Prof. Maria Paola Martelli was invited speaker at first Italian meeting of the Society of Hemato-Oncology, topic: ‘Is t...
26 November, 2019 -
ERC DAY 2007-2017 DIECI ANNI DI ERC – EUROPEAN RESEARCH COUNCIL
In occasion of the Perugia of the tenth anniversary of the ERC - European Research Council , University of Perugia organ...
26 November, 2019
